Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Microsoft offers U.S. government over $6 billion in savings on cloud services over 3 years

(NASDAQ:MSFT) Microsoft is the latest company to discount the cost of its software to the General Services Administration.

What immediate price reaction can be expected for MSFT stock, and is there potential for a short‑term breakout or pull‑back? Will the discount accelerate the shift of U.S. government cloud spend toward Azure compared to competing providers like AWS and Google Cloud? How will the $6 billion savings impact Microsoft’s revenue and earnings forecasts for the next 12 months?
Symbol: MSFT
Cloud
13 days ago
Read more cnbc_tech

AL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Air Lease Corporation Is Fair to Shareholders

(NYSE:AL) NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Air Lease Corporation (NYSE: AL) to Sumitomo Corporation, SMBC Aviation Capi...

How might the potential delay or derailment of the sale affect AL's short‑term liquidity and longer‑term strategic positioning? What are the chances that Halper Sadeh LLC's investigation will lead to a legal challenge or a higher bid for Air Lease Corporation? Is the $65 per share offer a premium over AL's current market price and comparable valuation metrics?
Symbol: AL
Mergers
13 days ago
Read more businesswire

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUSÂź (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

(NYSE:EBS) GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Adv...

How does this contract compare to recent government procurement trends for anthrax vaccines and what implications does it have for competitor positioning and market share? What impact will the announced deliveries through March 2026 have on the company's cash flow and short‑term stock valuation? How will the $30 million BARDA contract modification affect Emergent BioSolutions' revenue guidance and EPS estimates?
Symbol: EBS
Contracts
13 days ago
Read more globenewswire

BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism

(NASDAQ:BBIO) PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on geneti...

How does BridgeBio's development timeline and data expectations compare with competitors developing therapies for hypoparathyroidism or related skeletal dysplasias? What is the total addressable market and commercial upside for an oral therapy in post‑surgical hypoparathyroidism versus existing treatments? How will the upcoming Phase 2 proof‑of‑concept data for Encaleret affect BBIO's short‑term stock volatility?
Symbol: BBIO
Clinical trials
13 days ago
Read more globenewswire

XCharge Launches GridLink Across Europe, Powered by Proprietary Battery Technology for Enhanced Safety

(NASDAQ:XCH) HAMBURG, Germany--(BUSINESS WIRE)--XCharge North America (“XCharge NA”) and XCharge Europe (“XCharge EU”), subsidiaries of high-power EV charging and battery-integrated solution provid...

What are the regulatory and adoption risks for XCharge's proprietary battery technology in the EU market? What is the competitive positioning of GridLink against other EV charging solutions in Europe, and how might it influence market share? How will the GridLink launch affect XCH's revenue forecasts and earnings guidance?
Symbol: XCH
Product launch
13 days ago
Read more businesswire